Raymond James Financial’s Organogenesis Holdings ORGO Stock Holding History

Raymond James Financial’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$454K	Buy	186,977 +47,335	+34%	+$116K	﹤0.01%	4578
2026 Q1	$331K	Sell	139,642 -281,843	-67%	-$976K	﹤0.01%	4605
2025 Q4	$2.18M	Buy	421,485 +4,998	+1%	+$24.2K	﹤0.01%	3209
2025 Q3	$1.76M	Sell	416,487 -27,753	-6%	-$129K	﹤0.01%	3265
2025 Q2	$1.63M	Buy	444,240 +23,919	+6%	+$89.2K	﹤0.01%	3249
2025 Q1	$1.82M	Buy	+420,321	New	+$1.7M	﹤0.01%	3059

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Raymond James Financial's ORGO Position: Q2 2026 in Review

Raymond James Financial increased its Organogenesis Holdings (ORGO) stake by 34% in Q2 2026, buying an estimated $116K and bringing the position to 186,977 shares worth $454K. The position accounts for ﹤0.01% of the portfolio, ranked #4578.

Raymond James Financial first reported a position in ORGO in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.18M in Q4 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Raymond James Financial held 186,977 shares of Organogenesis Holdings worth $454K as of Q2 2026.
Raymond James Financial bought 47,335 Organogenesis Holdings shares in Q2 2026, an estimated $116K.
Organogenesis Holdings made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4578 holding.
Raymond James Financial first reported a position in Organogenesis Holdings in Q1 2025 and has held it in 6 quarters since.
Raymond James Financial's Organogenesis Holdings position peaked at $2.18M in Q4 2025.
134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.